First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of ...

Medtronic plc , a global leader in healthcare technology, today announced two major milestones for the Afferatm Sphere-360tm catheter, a first-of-its-kind, all-in-one mapping and single-shot pulsed ...

A recent review concluded that artificial intelligence (AI) is revolutionising cardiology by transforming clinical practice.

The Atrial Fibrillation (AFib) market is currently undergoing substantial expansion, fueled by several converging factors ...

Discover how wearable technology, AI diagnostics, and remote monitoring are reshaping heart health for individuals over 40 in ...

Dr Emma Svennberg, cardiologist in Stockholm and first author of the consensus paper, noted that modern AF care requires a more streamlined and holistic approach. She highlighted the need to address ...

Svennberg E et al. Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference. Europace, 15 Dec 2025. DOI: ...

EAST LANSING, Mich. (WILX) - Michigan State University researchers have developed miniature hearts from human stem cells that could advance treatment for atrial fibrillation, a heart condition ...

Abstract: A two-layer analysis approach of the atrial fibrillation episode detection algorithm tested in the MIT-BIH atrial fibrillation database (MIT-BIH AFDB) is proposed in the paper. We use ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...

Patients with irregular heartbeats — caused by atrial fibrillation (AF), the most common heart rhythm disorder — have historically been warned to limit or eliminate caffeine. But a new study suggests ...